Other languages SanBio Company Limited

Equities

4592

JP3336750009

Delayed Japan Exchange Other stock markets 07:00:00 02/05/2024 BST			5-day change	1st Jan Change
430 ^JPY	+2.38%		+3.12%	-38.75%

03-19	SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	MT
03-19	Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SanBio Books Non-operating Income, Extraordinary Gains, Deferred Income Taxes in Fiscal 2024	03-19
SanBio's FY2024 Attributable Net Loss Narrows on Lower Costs, Forex Gains	03-19
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2025, and Full Fiscal Year Ending January 31, 2025	03-18
Sanbio Co., Ltd. Provides Update on Status of Manufacturing and Marketing Approval for Sb623 Chronic Traumatic Brain Injury Program in Japan	01-25
SanBio Logs Extraordinary Gain from Asset Sale of US Unit	12-21
Sanbio Widens Nine-Month Attributable Net Loss	12-15
SanBio Company Limited Provides Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	12-14
SanBio Co., Ltd. Updates on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14/06/23
SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and Full Year Ending January 31, 2024	14/06/23
Japan Stock Market Remains Jittery Despite Damage Control; Toyota Industries Plummets 11% Over Fresh Data Scandal	20/03/23
SanBio's FY23 Loss Widens	20/03/23
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2024, and Full Fiscal Year Ending January 31, 2024	17/03/23
SanBio Co., Ltd. Announces Board Changes	20/01/23
Rosier FY23 Economic Outlook Pulls Japanese Shares Out of Losses; Rakuten's S&P Rating Deteriorates	22/12/22
SanBio Company Limited Announces Establishment of In-House Facility and Acquisition of License for Packaging, Labeling and Storage of Regenerative Medicine Products	21/12/22
SanBio Posts Narrowed FY23 Nine-month Loss on Foreign Exchange Gains, Lower Expenses	16/12/22
SanBio Company Limited Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023	15/12/22
SanBio Co., Ltd. Concludes an Agreement with the Keio University School of Medicine on Joint Research for SB623 Targeting Alzheimer's-Type Dementia	29/11/22
Tokyo finit la semaine en baisse, les taux américains inquiètent	21/10/22
Japanese Stocks Decline Under Inflationary Pressure; SanBio Shares Sink 18%	21/10/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages SanBio Company Limited

Equities

4592

JP3336750009

Other languages

Filters